XML Financial’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-68,478
Closed -$2.53M 324
2022
Q2
$2.53M Buy
68,478
+300
+0.4% +$47.4K 0.57% 44
2022
Q1
$2.87M Hold
68,178
0.34% 84
2021
Q4
$4.04M Hold
68,178
0.49% 61
2021
Q3
$4.41M Hold
68,178
0.59% 53
2021
Q2
$3.05M Buy
68,178
+312
+0.5% +$60.5K 0.67% 40
2021
Q1
$2.91M Hold
67,866
0.71% 40
2020
Q4
$2.87M Hold
67,866
0.74% 36
2020
Q3
$2.21M Buy
67,866
+2,817
+4% +$403K 0.69% 36
2020
Q2
$1.5M Hold
65,049
0.52% 47
2020
Q1
$1.17M Buy
65,049
+308
+0.5% +$29.7K 0.51% 50
2019
Q4
$1.09M Buy
+64,741
New +$5.44M 0.4% 62

Other funds holding RGEN

XML Financial's RGEN Position: Q3 2022 in Review

XML Financial sold out of Repligen (RGEN) in Q3 2022, closing a stake of 68,478 shares — an estimated $2.53M sold.

XML Financial first reported a position in RGEN in Q4 2019 and held it in 11 quarters. The position peaked at $4.41M in Q3 2021. 434 funds tracked by Wall St. Rank hold RGEN as of Q3 2022.

  • XML Financial reported no remaining Repligen position as of Q3 2022 after selling out during the quarter.
  • XML Financial sold 68,478 Repligen shares in Q3 2022, an estimated $2.53M.
  • XML Financial first reported a position in Repligen in Q4 2019 and held it in 11 quarters.
  • XML Financial's Repligen position peaked at $4.41M in Q3 2021.
  • 434 funds tracked by Wall St. Rank held Repligen as of Q3 2022.

Based on XML Financial's 13F filing for Q3 2022, filed 4 Nov 2022.